Semaglutide vs. Tirzepatide: Which Is Better for Weight Loss?

If you've been looking into weight loss medications, you've probably come across two names more than any others: semaglutide and tirzepatide. Both belong to the GLP-1 receptor agonist family, both are injectable, and both have shown remarkable results in clinical trials. But they're not identical — and the differences matter when you're deciding which one might work best for you.

Let me walk you through how these two medications compare, so you can have an informed conversation with your doctor.

How Semaglutide Works

Semaglutide — the active ingredient in Ozempic and Wegovy — mimics a hormone called GLP-1 that your body naturally produces after eating. This hormone tells your brain you're full, slows down how quickly food leaves your stomach, and helps regulate blood sugar.

When you take semaglutide, you're essentially amplifying a signal your body already knows how to use. The result is reduced appetite, fewer cravings, and a more controlled relationship with food. In clinical trials, participants on semaglutide lost an average of 15-17% of their body weight over 68 weeks.

How Tirzepatide Works

Tirzepatide — sold as Mounjaro and Zepbound — takes a slightly different approach. Instead of targeting just one hormone receptor, it targets two: GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). This dual-action mechanism is sometimes called a "twincretin."

GIP plays its own role in metabolism, including how your body stores and uses fat. By activating both pathways simultaneously, tirzepatide may produce a stronger metabolic effect. In the SURMOUNT trials, participants on the highest dose of tirzepatide lost an average of 22.5% of their body weight — a genuinely striking number.

Head-to-Head: Weight Loss Results

While there hasn't been a large-scale direct head-to-head trial published yet, the data we have from separate clinical trials suggests tirzepatide may produce greater average weight loss than semaglutide. Here's a rough comparison:

• Semaglutide (2.4 mg/week): Average weight loss of 15-17% over 68 weeks
• Tirzepatide (15 mg/week): Average weight loss of 20-22% over 72 weeks

These are averages, which means individual results vary widely. Some people respond better to one medication than the other, and there's no reliable way to predict which one will work best for you without trying it.

Side Effects: What to Expect

Both medications share similar side effects because they work on overlapping pathways. The most common include:

• Nausea (especially during dose escalation)
• Vomiting
• Diarrhea or constipation
• Reduced appetite
• Abdominal discomfort

Are Side Effects Worse With One or the Other?

In clinical trials, gastrointestinal side effects were reported at roughly similar rates for both medications. However, individual tolerance varies. Some patients who struggle with nausea on semaglutide do fine on tirzepatide, and vice versa.

Both medications use a gradual dose-escalation schedule specifically to minimize side effects. Starting low and increasing slowly gives your body time to adjust.

Dosing and Administration

Both are weekly subcutaneous injections, typically self-administered in the abdomen, thigh, or upper arm using a pen device.

• Semaglutide: Starts at 0.25 mg/week, gradually increases to a target dose of 2.4 mg/week
• Tirzepatide: Starts at 2.5 mg/week, gradually increases to a maximum of 15 mg/week

The escalation timeline is similar — roughly 16-20 weeks to reach the full dose, depending on how well you tolerate each increase.

Cost and Insurance Coverage

This is often the deciding factor, honestly. Both medications are expensive without insurance — often $1,000 or more per month at retail price.

Insurance coverage varies significantly depending on your plan. Some insurers cover one but not the other. Some require prior authorization or evidence that you've tried other weight loss approaches first. And formulary placement can change, so what's covered today might shift next year.

If cost is a barrier, compounded versions of semaglutide have become available through specialty pharmacies, which can be significantly less expensive. We can discuss these options during your visit.

Who Might Prefer Semaglutide?

You might lean toward semaglutide if:

• Your insurance covers it but not tirzepatide
• You're also managing type 2 diabetes (semaglutide has a long track record for glycemic control)
• You want a medication with more years of real-world safety data
• Cost is a factor and compounded semaglutide is an option

Who Might Prefer Tirzepatide?

Tirzepatide might be the better fit if:

• You're looking for potentially greater weight loss
• You haven't responded well to semaglutide
• Your insurance covers it
• You have significant insulin resistance (the dual mechanism may offer additional metabolic benefits)

The Bottom Line

Both semaglutide and tirzepatide are genuinely effective weight loss medications. Tirzepatide appears to edge ahead in average weight loss, but semaglutide has a longer track record and more available formulations. Neither is universally "better" — the right choice depends on your health profile, insurance situation, and how your body responds.

The most important thing is that you don't have to figure this out alone.

How Coral Health Can Help

At Coral Health, we offer telehealth consultations with Dr. Tae Y. Kim, DO, to help you evaluate whether semaglutide, tirzepatide, or another approach is the right fit for your weight loss goals. We'll review your medical history, discuss your options honestly, and build a plan that makes sense for your life — not just your scale. [Schedule a consultation](/start) to get started.

---

Related Articles

• [How Much Does Semaglutide Cost Per Month?](/blog/semaglutide-cost-per-month-2026)
• [Compounded Semaglutide: What You Need to Know](/blog/compounded-semaglutide-what-to-know)
• [How GLP-1 Works for Weight Loss](/blog/how-glp1-works-for-weight-loss)